Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
NewGenIvf Group ( (NIVF) ) has shared an announcement.
On December 23, 2025, NewGenIvf Group’s board approved a one-for-three reverse stock split covering all issued and unissued Class A and Class B ordinary shares and preferred shares, to be implemented without a shareholder vote under the company’s governing documents and applicable BVI law. The reverse split will take effect at 12:01 a.m. ET on January 26, 2026, when the company’s Class A ordinary shares will begin trading on a split-adjusted basis on Nasdaq under the existing symbol “NIVF” but with a new CUSIP, reducing the number of outstanding Class A ordinary shares from 2,948,080 to approximately 982,694, adjusting all related options, warrants and convertible securities on a one-for-three basis, and issuing whole shares in lieu of fractional positions, all without altering par value or the company’s unlimited authorized share capital, thereby tightening the share float while keeping the overall capital framework intact for existing investors and market participants.
More about NewGenIvf Group
NewGenIvf Group Limited, headquartered in Bangkok, Thailand, is a foreign private issuer listed on the Nasdaq Capital Market under the ticker “NIVF.” The company’s share capital structure includes Class A and Class B ordinary shares and preferred shares with no par value, and it operates under the BVI Business Companies Act with an unlimited authorized share capital, providing flexibility in its equity structure as a publicly traded entity.
Average Trading Volume: 957,031
Technical Sentiment Signal: Sell
Current Market Cap: $737.4K
For an in-depth examination of NIVF stock, go to TipRanks’ Overview page.